Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.61 |
| ▸ | PPARG | P37231 | 3/20 | 0.61 |
| ▸ | PPARD | Q03181 | 3/20 | 0.61 |
| ▸ | PPARA | Q07869 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | FABP4 | P15090 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | F7 | P08709 | 2/20 | 0.61 |
| ▸ | F3 | P13726 | 2/20 | 0.61 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8814525 | 0.81 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL32674589 | 0.81 | FAAH (0.64) | TERTPTPN1PPARGPPARDPPARA | |
| Oleic Acid SCHEMBL31462131 | 0.81 | PPARG (0.85) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL3065252 | 0.81 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL9745146 | 0.81 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL19011847 | 0.81 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL220791 | 0.79 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL9228821 | 0.79 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL1669629 | 0.79 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL10521045 | 0.79 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080253960-A1 | Lipoprotein-Based Nanoplatforms | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CENTER FOR TECHNOLOGY TRANSFER (US) | 2008-10-16 | — | — | US | disclosed |
| EP-1778298-A2 | LIPOPROTEIN NANOPLATFORMS | The Trustees of The University of Pennsylvania (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006073419-A2 | LIPOPROTEIN NANOPLATFORMS | ZHENG GANG (US) | 2006-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080253960-A1 | Lipoprotein-Based Nanoplatforms | LDLR, APOL1, LRP6 | TERT 3976/4885PTPN1 193/4885PPARG 496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.